- Home
- RNGR vs TSHA Comparison
RNGR vs TSHA Comparison
Compare RNGR & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNGR
- TSHA
- Stock Information
- Founded
- RNGR 2017
- TSHA 2019
- Country
- RNGR United States
- TSHA United States
- Employees
- RNGR N/A
- TSHA N/A
- Industry
- RNGR Oilfield Services/Equipment
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- RNGR Energy
- TSHA Health Care
- Exchange
- RNGR Nasdaq
- TSHA Nasdaq
- Market Cap
- RNGR 279.8M
- TSHA 397.8M
- IPO Year
- RNGR 2017
- TSHA 2020
- Fundamental
- Price
- RNGR $11.21
- TSHA $2.10
- Analyst Decision
- RNGR Hold
- TSHA Strong Buy
- Analyst Count
- RNGR 2
- TSHA 8
- Target Price
- RNGR $12.50
- TSHA $6.63
- AVG Volume (30 Days)
- RNGR 118.5K
- TSHA 2.9M
- Earning Date
- RNGR 04-29-2025
- TSHA 05-16-2025
- Dividend Yield
- RNGR 2.14%
- TSHA N/A
- EPS Growth
- RNGR 27.70
- TSHA N/A
- EPS
- RNGR 0.87
- TSHA N/A
- Revenue
- RNGR $569,400,000.00
- TSHA $8,333,000.00
- Revenue This Year
- RNGR $11.70
- TSHA N/A
- Revenue Next Year
- RNGR N/A
- TSHA N/A
- P/E Ratio
- RNGR $12.77
- TSHA N/A
- Revenue Growth
- RNGR N/A
- TSHA N/A
- 52 Week Low
- RNGR $9.27
- TSHA $1.05
- 52 Week High
- RNGR $18.45
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- RNGR 37.16
- TSHA 58.01
- Support Level
- RNGR $11.05
- TSHA $1.85
- Resistance Level
- RNGR $12.39
- TSHA $2.73
- Average True Range (ATR)
- RNGR 0.60
- TSHA 0.27
- MACD
- RNGR -0.01
- TSHA 0.04
- Stochastic Oscillator
- RNGR 24.06
- TSHA 58.47
About RNGR Ranger Energy Services Inc.
Ranger Energy Services Inc is a provider of onshore high-specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well-site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions, and Ancillary Services, of which key revenue is derived from the High Specification Rigs segment.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.